Sign up for the QMED & MD+DI Daily newsletter.
Pressed for time? Here's the medtech news you need most, in one minute or less.
Omar Ford
February 21, 2020
1 Min Read
Your time is valuable, so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.Image by OpenClipart-Vectors on Pixabay
Class I Recalls for Abbott and Medtronic
Both Abbott Laboratories and Medtronic faced Class I Recalls last week. Abbott faced a recall of specific lots of its NC Trek RX Coronary Dilatation Catheter. Medtronic’s MiniMed Insulin Pump was the subject of a recall.
Insulet Corners CGM Market with Two High Profile Collaborations
Last week, Insulet revealed it had snared two partnerships that will help it continue its strong momentum in the continuous glucose monitoring (CGM) market. The Billerica, MA-based company signed agreements with both Abbott Laboratories and DexCom.
Grail Keeps Cranking Out Milestones
The Menlo Park, CA-based company said it has initiated PATHFINDER, a multi-center study. PATHFINDER will mark the first time Grail’s test results will be returned to healthcare providers and communicated to participants to help guide appropriate diagnostic workups for more than 50 cancer types.
About the Author(s)
You May Also Like
